Last updated: January 2, 2024
Sponsor: Ottawa Hospital Research Institute
Overall Status: Active - Recruiting
Phase
2
Condition
Osteoarthritis
Treatment
Patient Reported Questionnaires
Blood/Urine Collection
EOS Scan
Clinical Study ID
NCT04080466
20190456
Ages > 18 All Genders Accepts Healthy Volunteers
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
- Skeletally mature patient undergoing cam resection by hip arthroscopy with hip painlonger than 6 months
- Absence of arthritis (Tonnis Grade 0 or 1)
- Absence of dysplasia (LCEA > 25°) or overcoverage (LCEA > 39°)
- Alpha angle greater than 55° on multiplanar imaging
- Subject is over the age of 18 years old at time of enrollment
- Subject is willing and able to complete required study visits and assessments
- Subject is willing to sign the approved Informed Consent Form Group 2 Inclusion Criteria:
- Normal femoral head neck contour and no evidence of dysplasia
- Subject is over the age of 18 years old at time of enrollment
- Subject is willing and able to complete required study visits and assessments
- Subject is willing to sign the approved Informed Consent Form
Exclusion
Exclusion Criteria:
- Prior joint replacement surgery in any lower-limb joint due to OA
- History of lower-limb joint or back injury in the last year that impairs mobility
- Metallic prosthesis
- Worked with metal, metal fragments in the eye
- Blood transmittable disease(s)
- In vivo devices (Aneurysm clip(s), Pacemaker, ICD, Implanted hearing device)
- Extreme claustrophobia
- Overweight or obese (BMI > 30) and/or waist circumference >102cm in men and >88cm inwomen
- Diagnosis of Parkinson's or uncontrollable tremors
- Known history of early OA in the immediate family
- Pregnant, Breastfeeding, or planning to get pregnant
- Cognitive impairment that prevents accurate completion of patient-reported outcomequestionnaires
- Patient unable/unwilling to complete all required follow-up visits
- Participants who have been exposed to other sources of radiation within the last year (Bringing radiation exposure above annual maximum)
Study Design
Total Participants: 58
Treatment Group(s): 7
Primary Treatment: Patient Reported Questionnaires
Phase: 2
Study Start date:
February 20, 2021
Estimated Completion Date:
January 31, 2025
Study Description
Connect with a study center
The Ottawa Hospital
Ottawa, Ontario K1H 8L6
CanadaActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.